Skip to content

Clinical trials

Phase 1 Generalized Anxiety Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 1 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20081
20093
20181
20201
20221
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Not yet recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
AbbVie2
Beijing Tongren Hospital1
Beijing Union Pharmaceutical Factory Ltd1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Penn State University1
Texas Tech University1
Trinity Hypertension & Metabolic Research Institute1
University of Florida1
University of Massachusetts, Boston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder15
Anxiety Disorders3
Panic Disorder3
Phobia, Social3
Major Depressive Disorder2
Obsessive-Compulsive Disorder2
Anxiety, Separation1
Bipolar Disorder1
Fractures, Stress1
Mental Disorders1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.